Michael E. Farkouh

Active 1996–2025

153
Papers
25,290
Citations
81
h-index
145
i10-index

Citations

Citations per year for Michael E. Farkouh1980: 1 citations1988: 1 citations1996: 1 citations1997: 1 citations1998: 2 citations1999: 3 citations2000: 14 citations2001: 14 citations2002: 26 citations2003: 35 citations2004: 26 citations2005: 38 citations2006: 43 citations2007: 51 citations2008: 58 citations2009: 67 citations2010: 66 citations2011: 70 citations2012: 96 citations2013: 143 citations2014: 164 citations2015: 198 citations2016: 211 citations2017: 202 citations2018: 200 citations2019: 674 citations2020: 866 citations2021: 980 citations2022: 772 citations2023: 563 citations2024: 902 citations2025: 424 citations2026: 27 citations1981–1987: no citations, so these years are not shown1989–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,782 citing papers, 22.2% of this breakdownUnited Kingdom: 1,049 citing papers, 8.4% of this breakdownChina: 796 citing papers, 6.4% of this breakdownCanada: 754 citing papers, 6% of this breakdownItaly: 662 citing papers, 5.3% of this breakdownGermany: 554 citing papers, 4.4% of this breakdownNetherlands: 476 citing papers, 3.8% of this breakdownFrance: 432 citing papers, 3.4% of this breakdownSpain: 389 citing papers, 3.1% of this breakdownAustralia: 383 citing papers, 3.1% of this breakdownSwitzerland: 260 citing papers, 2.1% of this breakdownDenmark: 249 citing papers, 2% of this breakdown
0%22.2%Other 29.8%

Fields

  • Medicine78.3%
  • Neuroscience6%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology3.1%
  • Psychology1.1%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Other5.5%

Topics

  • Cardiac Imaging and Diagnostics3.5%
  • Coronary Interventions and Diagnostics3.2%
  • Acute Myocardial Infarction Research3.1%
  • Diabetes Treatment and Management3%
  • Lipoproteins and Cardiovascular Health2.6%
  • Antiplatelet Therapy and Cardiovascular Diseases2.2%
  • Other82.4%

Coauthors

All papers

Open in search
  1. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 386

  2. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2013 cited by 1,770

  3. Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects

    Authors: , , , , , , - JAMA Psychiatry 2014 cited by 939

  4. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 578

  5. Inflammation, Immunity, and Infection in Atherothrombosis

    Authors: , , , , , , , - Journal of the American College of Cardiology 2018 cited by 539

  6. Strategies for Multivessel Revascularization in Patients with Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,902

  7. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 404

  8. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2018 cited by 735

  9. Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life

    Authors: , , , , , - JAMA Cardiology 2020 cited by 243

  10. Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events

    Authors: , , , , , , , , - Arthritis & Rheumatology 2015 cited by 323

  11. Trial of an Intervention to Improve Acute Heart Failure Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 147

  12. AKI and Long-Term Risk for Cardiovascular Events and Mortality

    Authors: , , , , , , - Journal of the American Society of Nephrology 2016 cited by 383

  13. Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy

    Authors: , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2021 cited by 163

  14. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 173

  15. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 129

  16. Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients

    Authors: , , , , , , , , , , - JAMA 2013 cited by 503

  17. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers

    Authors: , , , - Journal of the American College of Cardiology 2020 cited by 225

  18. Clopidogrel Pharmacogenetics

    Authors: , , , , , , , , , , , , , , , , - Circulation Cardiovascular Interventions 2019 cited by 221

  19. Adherence to Statin Therapy Among US Adults Between 2007 and 2014

    Authors: , , , , , , , , , - Journal of the American Heart Association 2019 cited by 152

  20. Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 cited by 173

  21. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

    Authors: , , , , , , , , , , , , - The Lancet 2011 cited by 532

  22. Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 412

  23. Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

    Authors: , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 166

  24. A Polypill Strategy to Improve Adherence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 351